US$ 27.02
glp-1 and dementia In New Trials, Ozempic's 'Miracle Drug' Image Takes a Hit GLP-1 and the Degenerating Brain:
Description
GLP-1 Agonists: Wonder Drugs of the 21st Century

If phase 3 results remain positive, regulatory submissions may begin in 2026, meaning orforglipron could become available in late 2026 or 2027, depending on MHRA and NICE approval timelines

At first glance, those numbers reflect healthy year-over-year increases, as Mounjaro sales more than doubled, zooming 121% from $1.409 billion in July-September 2023

Which medications does Honest Care support

doi: 10.3389/fphar.2025.1529652

They can be viewed on a computer, tablet or mobile phone
